Sales growth of leading antacid tablet brands in the U.S. 2019

The statistic shows the sales growth of leading brands of antacid tablets in the United States in 2019. The brand Tums had a sales growth of nearly 14.3 percent in the United States in 2019 compared to the prior sales year.

Antacid tablets in the United States

Antacids, for the most part, are a non-prescription medicine (over-the-counter) used to relieve heartburn or indigestion caused by excess stomach acid. They either directly neutrailze acidity, increasing the pH, or reversibly reduce or block the secretion of acid by gastric cells.Disregarding private label brands, Nexium 24R was the leading antacid tablet brand in the United States,. Prilosec OTC is owned by the American multi-national consumer goods company Procter & Gamble, the second leading antacid tablet vendor in the United States, excluding private label vendors.

Despite the minor decrease in sales in this product category, pharmacy sales are growing in the grocery channel for a number of reasons. For one, having a pharmacy presence creates many opportunities for retailers to provide additional services to customers. As a result, shelf strategy has become a primary focus for retailers. Placing products where consumers expect to find it is critical; creating a visual interruption at the point of purchase has proven to be a cost effective and successful way to generate awareness and trial in the category.